1. Cell Cycle/DNA Damage
    Epigenetics
  2. PARP
  3. PARP Inhibitors

PARP Inhibitors

PARP

PARP1

PARP2

PARP3

PARP4

TNKS1/PARP5A

TNKS2/PARP5B

PARP10

Your Search Returned No Results.

Sorry. There is currently no product that acts on isoform together.

Please try each isoform separately.

PARP Inhibitors
Product Name PARP PARP1 PARP2 PARP3 PARP4 TNKS1/PARP5A TNKS2/PARP5B PARP10 Purity
Olaparib  
PARP-1, IC50: 5 nM
PARP-2, IC50: 1 nM
   
tankyrase-1, IC50: 1.5 μM
    99.98%
Talazoparib  
PARP1, Ki: 1.2 nM
PARP2, Ki: 0.87 nM
          99.83%
XAV-939  
ARTD1, IC50: 5500 nM
ARTD2, IC50: 479 nM
   
TNKS1, IC50: 5 nM
TNKS2, IC50: 2 nM
  98.04%
Niraparib  
PARP-1, IC50: 3.8 nM
PARP-2, IC50: 2.1 nM
PARP-3, IC50: 1300 nM
V-PARP, IC50: 330 nM
TANK-1, IC50: 570 nM
    99.93%
Veliparib  
PARP-1, Ki: 5.2 nM
PARP-2, Ki: 2.9 nM
          >98.0%
Dehydrocorydaline
PARP
             
RK-287107          
tankyrase-1, IC50: 14.3 nM
tankyrase-2, IC50: 10.6 nM
 
PARP-2-IN-1    
PARP-2, IC50: 11.5 nM
         
Rucaparib phosphate  
PARP-1, Ki: 1.4 nM
            99.89%
Niraparib tosylate  
PARP-1, IC50: 3.8 nM
PARP-2, IC50: 2.1 nM
PARP-3, IC50: 1300 nM
V-PARP, IC50: 330 nM
TANK-1, IC50: 570 nM
    99.52%
Pamiparib
PARP
              99.97%
Rucaparib Camsylate  
PARP-1, Ki: 1.4 nM
            99.81%
PJ34
PARP, IC50: 110 nM
PARP-1, IC50: 110 nM
PARP-2, IC50: 86 nM
          >98.0%
NMS-P118  
PARP-1, Kd: 9 nM
PARP-2, Kd: 1390 nM
          99.08%
G007-LK          
TNKS1, IC50: 46 nM
TNKS2, IC50: 25 nM
  99.24%
AZD-2461  
PARP1, IC50: 5 nM
PARP2, IC50: 2 nM
PARP3, IC50: 200 nM
        98.39%
AG14361  
PARP-1, Ki: 0.5 nM
            99.41%
Iniparib  
PARP1
            99.65%
A-966492  
PARP-1, Ki: 1 nM
PARP-2, Ki: 1.5 nM
          98.59%
3-Aminobenzamide
PARP, IC50: 50 nM
              99.92%
NVP-TNKS656    
PARP2, IC50: 32 μM
     
TNKS2, IC50: 6 nM
  99.14%
Talazoparib 8R,9S  
PARP-1, IC50: 144 nM
            95.08%
Niraparib R-enantiomer  
PARP-1, IC50: 2.4 nM
            98.58%
BGP-15
PARP, IC50: 120 μM
              >98.0%
MN-64  
ARTD1, IC50: 19.1 μM
ARTD2, IC50: 39.4 μM
   
TNKS1, IC50: 6 nM
TNKS2, IC50: 72 nM
  98.22%
ME0328  
ARTD1/PARP1, IC50: 6.3 μM
ARTD2/PARP2, IC50: 10.8 μM
ARTD3/PARP3, IC50: 0.89 μM
 
ARTD5/TNKS1, IC50: 47.3 μM
ARTD6/TNKS2, IC50: 34.3 μM
ARTD10/PARP10, IC50: 71.3 μM
99.34%
UPF 1069  
PARP-1, IC50: 8 μM
PARP-2, IC50: 0.3 μM
          98.88%
Niraparib hydrochloride  
PARP-1, IC50: 3.8 nM
PARP-2, IC50: 2.1 nM
PARP-3, IC50: 1300 nM
V-PARP, IC50: 330 nM
TANK-1, IC50: 570 nM
   
K-756          
TNKS1, IC50: 31 nM
TNKS2, IC50: 36 nM
  >99.0%
Rucaparib  
PARP-1, Ki: 1.4 nM
           
WD2000-012547  
PARP-1, pKi: 8.221